Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-08

Clinical Trial Update: Biofreedom Stent in All Comer Population

View source ↗

Summary

The all-comers trial evaluating the BioFreedom stent in coronary artery disease has completed. Sponsor: University of Roma La Sapienza.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioFreedom Stent

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Status: COMPLETED